

[ Mon, Mar 11th 2024
] - WOPRAI

[ Thu, Dec 14th 2023
] - WOPRAI

[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI
[ Tue, Dec 12th 2023
] - WOPRAI

[ Fri, Jul 14th 2023
] - WOPRAI

[ Fri, Jun 23rd 2023
] - WOPRAI

[ Tue, May 09th 2023
] - WOPRAI

[ Tue, Apr 04th 2023
] - WOPRAI

[ Tue, Mar 14th 2023
] - WOPRAI

[ Wed, Mar 01st 2023
] - WOPRAI

[ Tue, Feb 28th 2023
] - WOPRAI

[ Tue, Jan 31st 2023
] - WOPRAI

[ Mon, Jan 09th 2023
] - WOPRAI

[ Thu, Nov 10th 2022
] - WOPRAI

[ Mon, Oct 03rd 2022
] - WOPRAI

[ Thu, Sep 08th 2022
] - WOPRAI

[ Thu, Sep 01st 2022
] - WOPRAI

[ Mon, Aug 08th 2022
] - WOPRAI

[ Fri, Aug 05th 2022
] - WOPRAI

[ Mon, Jul 11th 2022
] - WOPRAI

[ Wed, Jul 06th 2022
] - WOPRAI

[ Wed, Jun 22nd 2022
] - WOPRAI

[ Tue, Jun 14th 2022
] - WOPRAI

[ Wed, May 25th 2022
] - WOPRAI

[ Tue, May 17th 2022
] - WOPRAI

[ Fri, Feb 25th 2022
] - WOPRAI

[ Wed, Jan 05th 2022
] - WOPRAI

[ Tue, Dec 21st 2021
] - WOPRAI

[ Tue, Dec 07th 2021
] - WOPRAI

[ Tue, Jul 13th 2021
] - WOPRAI

[ Tue, Mar 09th 2021
] - WOPRAI

[ Fri, Mar 06th 2020
] - WOPRAI
[ Fri, Mar 06th 2020
] - WOPRAI

[ Tue, Jul 11th 2017
] - WOPRAI

[ Mon, Jul 10th 2017
] - WOPRAI
Neena Bitritto-Garg Maintained (AMLX) at Strong Buy with Decreased Target to $8 on, Mar 11th, 2024
Neena Bitritto-Garg of Deutsche Bank, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Decreased Target from $36 to $8 on, Mar 11th, 2024.
Neena has made no other calls on AMLX in the last 4 months.
There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 1 agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Umer Raffat of "Evercore ISI Group" Downgraded from Buy to Hold on, Friday, March 8th, 2024
This is the rating of the analyst that currently disagrees with Neena
- Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy with Increased Target to $32 on, Friday, March 8th, 2024